Coronavirus
NICE Guidance
NG191: COVID-19 rapid guideline: managing COVID-19. Last updated June 2023.
TA878: Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19. Last updated June 2023. (Note that Casirivimab plus imdevimab is NOT recommended for treating acute COVID‑19 in adults in this TA)